0001567619-21-009606.txt : 20210511
0001567619-21-009606.hdr.sgml : 20210511
20210511194254
ACCESSION NUMBER: 0001567619-21-009606
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210430
FILED AS OF DATE: 20210511
DATE AS OF CHANGE: 20210511
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mueller Brian
CENTRAL INDEX KEY: 0001514980
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26727
FILM NUMBER: 21912990
MAIL ADDRESS:
STREET 1: C/O BIOMARIN PHARMACEUTICAL INC.
STREET 2: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC
CENTRAL INDEX KEY: 0001048477
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 680397820
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
BUSINESS PHONE: 4155066700
MAIL ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
4
1
doc1.xml
FORM 4
X0306
4
2021-04-30
0
0001048477
BIOMARIN PHARMACEUTICAL INC
BMRN
0001514980
Mueller Brian
105 DIGITAL DRIVE
NOVATO
CA
94949
0
1
0
0
EVP, Chief Financial Officer
Common Stock
2021-04-30
5
A
0
341
62.407
A
31357
D
Common Stock
2021-05-07
4
M
0
6709
28.23
A
38066
D
Common Stock
2021-05-07
4
S
0
6709
79.50
D
31357
D
Stock Option (Right to buy Common Stock)
28.23
2021-05-07
4
M
0
6709
0
D
2011-12-01
2021-05-30
Common Stock
6709
0.000
D
Represents shares acquired by the reporting person on April 30, 2021, pursuant to the issuer's Employee Stock Purchase Plan.
Trade made pursuant to a 10b5-1 plan executed on January 29, 2021.
Reflects the number of options outstanding after the transactions from this specific stock option grant.
/s/ Eric Fleekop, Attorney-in-Fact
2021-05-11